Clinical trial

Unravelling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma

NCT02225392 · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Other · Completed

Key facts

NCT number NCT02225392
Title Unravelling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma
Official title Unravelling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma
Acronym TASMA
Lead sponsor Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Other
Collaborators ZonMw: The Netherlands Organisation for Health Research and Development The Netherlands Asthma Foundation Boston Scientific Corporation Industry
Status Completed
Study type Interventional
Conditions Asthma, Bronchial Asthma
Intervention type Device, Procedure
Interventions Bronchial thermoplasty, Alair system (Boston Scientific, USA)
Enrollment 40
Start date Apr 1, 2014
Primary completion Dec 1, 2019
Completion Dec 1, 2019
First posted Aug 26, 2014
Last update posted Dec 5, 2022
Countries Netherlands, United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies